India's Pharmaceutical Exports

Country Profile

Georgia

Georgia is an emerging destination for Indian pharmaceutical exports — $29.4M in FY 2025–26, with 3.7× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $522K. The compound annual growth rate since FY2015 stands at 12.7%.

🇬🇪 $29.4M · 3.7× growth since FY2015 · 12.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$29.4M
Exports FY2025–26 DGCIS
3.7×
Growth FY2015→2026
12.7%
CAGR FY2015→2026
91%
Medicines Share
5
Product Categories Supplied
Georgia is an emerging destination for Indian pharmaceutical exports — $29.4M in FY 2025–26, with 3.7× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $522K. The compound annual growth rate since FY2015 stands at 12.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $26.6M (90.5%) Surgical & Hospital Supplies $1.16M (3.9%) Medicine Ingredients $810K (2.8%) Vaccines $522K (1.8%) Traditional & Herbal $300K (1.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Georgia in the RBI overseas direct investment dataset (2011–2026).